Biotech and Pharma Stocks

Small Caps is Australia's #1 site for news & information on ASX listed small cap companies.

Small Caps and affiliated companies accept no responsibility for any claim, loss or damage as a result of information provided or its accuracy. The information provided on this site is general in nature, not financial product advice, see a financial expert before making any investment decision. Your personal objectives, financial situation or needs have not been taken into consideration. There may be a conflict of interest present with commercial arrangements with companies and/or stock held. Small Caps or an associate may receive a commission for funds raised.

BIOTECH & PHARMA

MedAdvisor to provide digital health education programs to Top 10 global pharma company

Noxopharm’s US biotech subsidiary Nyrada IPO successfully raises $8.5m

Emerald Clinics puts medical cannabis ‘real world’ evidence in the spotlight with proposed ASX listing

Imugene granted HER-Vaxx immunotherapy patent in the United States

Immutep expands clinical trial for lead drug candidate efti

Little Green Pharma eyes ASX listing to grow medical cannabis exports

Cann Group and IDT Australia move closer to bringing medicinal cannabis products to market

CannPal secures commercial rights to CSIRO’s MicroMAX technology

Prescient Therapeutics receives encouraging efficacy results for leading cancer drug candidate PTX-200

Cogstate achieves best half year on record for clinical trial sales

Cann Group and IDT Australia prepare for commercial launch of medicinal cannabis product

Cann Global shoulders into ‘huge’ emerging African medicinal cannabis market

Clinical trial confirms Antisense Therapeutics drug can inhibit progression of Duchenne muscular dystrophy

Prescient Therapeutics confirms positive early results in drug trial for patients with platinum-resistant ovarian cancer

Paradigm Biopharmaceuticals gears up for busy year of clinical trials and regulatory submissions in 2020

Kazia Therapeutics’ lead brain cancer drug selected for international study

Respiri’s Wheezo product approved for sale following CE Mark and TGA registration

Cann Global secures rights to medicinal cannabis formulations used by Olivia Newton-John

Zoono delivers an effective tool in response to growing African swine fever epidemic

Impression Healthcare files patent for non-intrusive treatment of obstructive sleep apnoea

Cynata Therapeutics has positive pre-clinical results using Cymerus stem cell platform to treat sepsis